Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9 USD | -1.53% | +0.22% | +20.81% |
May. 08 | Talis Biomedical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 02 | North American Morning Briefing : Stocks Seen -2- | DJ |
Financials (USD)
Sales 2022 | 4.81M | Sales 2023 | 2.13M | Capitalization | 13.57M |
---|---|---|---|---|---|
Net income 2022 | -113M | Net income 2023 | -62M | EV / Sales 2022 | -17.6 x |
Net cash position 2022 | 96.61M | Net cash position 2023 | 57.06M | EV / Sales 2023 | -20.4 x |
P/E ratio 2022 |
-0.11
x | P/E ratio 2023 |
-0.22
x | Employees | 99 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 91.69% |
Latest transcript on Talis Biomedical Corporation
1 day | -1.53% | ||
1 week | +0.22% | ||
Current month | +4.41% | ||
1 month | -1.53% | ||
3 months | +5.63% | ||
6 months | +28.21% | ||
Current year | +20.81% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Kelley
CEO | Chief Executive Officer | 52 | 20-08-31 |
Director of Finance/CFO | 51 | 21-12-31 | |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Posard
BRD | Director/Board Member | 56 | 16-02-29 |
Randal Scott
BRD | Director/Board Member | 66 | 13-12-31 |
Kim Popovits
BRD | Director/Board Member | 65 | 20-07-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 9 | -1.53% | 9,207 |
24-05-23 | 9.14 | -0.54% | 6,261 |
24-05-22 | 9.19 | +3.84% | 4,829 |
24-05-21 | 8.85 | +1.72% | 1,531 |
24-05-20 | 8.7 | -3.12% | 22,100 |
Delayed Quote Nasdaq, May 24, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+20.81% | 16.4M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.98% | 40.65B | |
-10.87% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- TLIS Stock